75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Disclosure - Lease - Summary of Future Lease Payments Under Non-cancellable Leases (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Disclosure - Term Loan - Schedule of Principal Payments and Net Carrying Amount of Term Loan (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Organization and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Fair Value of Financial Assets and Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Fixed Assets, Net
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Term Loan
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Other Long-Term Debt
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Lease
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Common Stock
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Exclusive Licensing Agreement with a Related Party
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Technology License Agreement
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Net Income (Loss) Per Share
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Fixed Assets, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Term Loan (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Lease (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Common Stock (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Warrants (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Net Income (Loss) Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Fair Value of Financial Assets and Liabilities - Schedule of Information About Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Fair Value of Financial Assets and Liabilities - Schedule of Aggregate Fair Values of Warrant Liabilities, for Which Fair Value Determined by Level 3 Inputs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Fixed Assets, Net - Summary of Fixed Assets, Net (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Fixed Assets, Net - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Term Loan - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Term Loan - Schedule of Principal Payments and Net Carrying Amount of Term Loan (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Other Long-Term Debt - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Lease - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Lease - Schedule of Other Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Lease - Summary of Future Lease Payments Under Non-cancellable Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Common Stock - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Common Stock - Schedule of Common Stock Reserved For Future Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Warrants - Summary of Warrants Outstanding for Purchase of Common Stock (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation - Schedule of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation - Schedule of Fair Value of Stock Options Granted Was Estimated on Black-Scholes Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation - Summary of Restricted Stock Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Stock Options, Restricted Stock and Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Exclusive Licensing Agreement with a Related Party - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Technology License Agreement - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Net Income (Loss) Per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Net Income (Loss) Per Share - Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Segment Reporting - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Segment Reporting - Summary of Disaggregated Amounts that Comprise Research and Development and General and Administrative Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Weighted-Average Grant Date Fair Value, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted-Average Exercise Price, Cancelled or forfeited or expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Proceeds from the sale of fixed assets
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from Sale of Property, Plant, and Equipment, Total
Other research and development segment expenses
Other Research and Development Expense
Term Loan
Term Loan [Text Block]
Term loan.
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Preferred Stock, Shares Issued, Total
Preferred stock, Shares issued
Preferred Stock, Shares Issued
Preferred stock, shares issued
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Balance at December 31, 2024
Balance at June 30, 2025
Increase (Decrease) in Accounts Payable, Total
Accounts payable
Increase (Decrease) in Accounts Payable
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Dilutive effect of outstanding warrants for common stock
Plan Name
Plan Name [Axis]
Research and development:
Research and Development Expense [Abstract]
Equity [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
Operating expenses:
Operating Expenses [Abstract]
Level 2
Fair Value, Inputs, Level 2 [Member]
Increase or decrease in percentage rate of Pre-funded warrants not in excess
Increase or decrease in percentage rate of Pre-funded warrants not in excess
Increase or decrease in percentage rate of Pre-funded warrants not in excess
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Series B Conditional Warrants
Series B Conditional Warrants [Member]
Series B conditional warrants.
Common stock, shares authorized
Common Stock, Shares Authorized
Share-Based Payment Arrangement, Tranche Three [Member]
Tranche Three
MASSACHUSETTS
Massachusetts
Commercial Purposes At Price Of Cost Plus Percentage
Commercial purposes at a price of cost plus percentage
Commercial purposes at a price of cost plus percentage.
Document Fiscal Period Focus
Document Fiscal Period Focus
Schedule of other information related to operating leases.
Schedule of Other Information Related to Operating Leases [Table Text Block]
Schedule of Other Information
Entity Shell Company
Entity Shell Company
Class of warrant or right period
Class Of Warrant Or Right Period
Class of warrant or right period.
Other
Other Accrued Liabilities, Current
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalent
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Common Stock, Shares, Issued, Total
Common stock issued
Common stock, shares, issued
Common Stock, Shares, Issued
Loans Payable to Bank, Noncurrent
Term loan payable to a bank
Net carrying amount
Net carrying amount
Shares Available for Future Grant Under Stock Option Plan
Shares Available For Future Grant Under Stock Option Plan [Member]
Shares available for future grant under stock option plan.
Statement [Table]
Statement [Table]
Restricted Cash, Noncurrent
Restricted cash
Statement [Line Items]
Statement [Line Items]
Warrant [Member]
Warrants
Entity Filer Category
Entity Filer Category
Loan Agreement
Loan agreement.
Loan Agreement [Member]
Technology License Agreement [Abstract]
Technology license agreement.
Liabilities and Equity
Total liabilities and stockholders' equity
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Payables and Accruals [Abstract]
Less current portion
Current portion of term loan payable to a bank
Less current portion
Long-Term Debt, Current Maturities
Long-Term Debt, Current Maturities, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Exercisable as of June 30, 2025
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Axis]
Debt Instrument, Frequency of Periodic Payment
Debt instrument, payment
Facility and equipment costs
Facility And Equipment Costs
Facility and equipment costs.
Debt Instrument, Date of First Required Payment
Debt instrument, commencing date
License Agreement [Abstract]
License agreement.
Public offering price
Shares Issued, Price Per Share
Geographical [Domain]
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Additional Paid in Capital, Common Stock, Ending Balance
Additional Paid in Capital, Common Stock, Beginning Balance
Additional paid-in capital
Additional Paid in Capital, Common Stock
Debt Issuance Costs, Net, Total
Debt Issuance Costs, Net
Debt issuance costs
Related Party [Member]
Related Party
Future payment made upon the achievement of sales
Future Payment Made Upon The Achievement Of Sales
Future payment made upon the achievement of sales.
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Vesting [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of Stock Options, Shares, Granted
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders
Investment, Name [Axis]
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Net income (loss) per share, basic
Net income (loss) per share, basic
Noncancelable operating lease expiration date.
Noncancelable Operating Lease Expiration Date
Office space noncancelable operating lease expiration date
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of Stock Options, Shares Outstanding
Number of Stock Options, Shares Outstanding
Pre-funded warrants
Pre-funded Warrants [Member]
Pre-funded Warrants.
Pre-funded Warrants
Non-cash interest expense
Non Cash Interest Expense
Non-cash interest expense.
Total current liabilities
Liabilities, Current
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of Aggregate Fair Values of Warrant Liabilities, for Which Fair Value Determined by Level 3 Inputs
Accretion of debt discount
Accretion of debt discount.
Class of warrant or right exercise average market price per share.
Class Of Warrant Or Right Exercise Average Market Price Per Share
Class of warrant or right exercise average market price per share
Equity, Attributable to Parent [Abstract]
Stockholders' equity
Entity Small Business
Entity Small Business
Increase (Decrease) in Accrued Liabilities, Total
Accrued expenses
Increase (Decrease) in Accrued Liabilities
Reserved for issuance upon exercise
Stock Reserved for Issuance During Period Shares Warrant Exercised
Stock reserved for issuance during period shares warrant exercised.
Cash proceeds Amount Equal to at least from the Issuance and Sale of Equity Securities.
Cash proceeds Amount Equal to at least from the Issuance and Sale of Equity Securities
Cash proceeds amount equal to at least from the issuance and sale of equity securities
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Common Stock
Incremental common shares attributable to dilutive effect of conversion of common stock
Dilutive effect of outstanding stock options (as converted to common stock)
Non-refundable fee
Non Refundable Fee
Non-refundable fee.
Sale of Stock, Price Per Share
Common stock, public offering price
Stock Options, Restricted Stock and Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gross Proceeds Before Deducting Underwriting Discounts and Commissions and Other Offering Expenses
Gross Proceeds Before Deducting Underwriting Discounts and Commissions and Other Offering Expenses
Gross proceeds before deducting underwriting discounts and commissions, and offering expenses
Schedule of Common Stock Reserved For Future Issuance
Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]
Schedule of common stock reserved for future issuance.
Leases [Abstract]
Lessee, Lease, Description [Line Items]
Amendment Flag
Amendment Flag
Debt instrument final payment fee
Debt Instrument Final Payment Fee
Final payment fee
Class of warrant or right consecutive trading days 1.
Class Of Warrant Or Right Consecutive Trading Days 1
Number of consecutive days
Technology License Agreement [Line Items]
Technology License Agreement [Line Items]
Technology license agreement.
SHARES OF COMMON STOCK SUBJECT TO WARRANTS
Class of warrants issued
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Equity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Increase (Decrease) in Operating Lease Liability
Lease liability
Payments to Acquire Notes Receivable
Payment for outstanding note balance and accrued interest due
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock
Common Stock [Member]
Long-Term Debt, Maturity, Year One
2026
Weighted-Average Exercise Price, Granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Debt instrument subject to prepayment premium percentage.
Debt Instrument Subject to Prepayment Premium Percentage
Debt instrument subject to prepayment premium percentage
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Less accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
Class Of Warrant Or Right Extended Expiration Dates
Extended expiration dates
Class of warrant or right extended expiration dates.
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Fair Value of Stock Options Granted Was Estimated on Black-Scholes Options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Earnings Per Share [Abstract]
Supplemental Cash Flow Information [Abstract]
Supplemental cash flow information:
Pre-clinical research
Pre-clinical research
Outstanding Stock Options (As Converted To Common Stock)
Stock Options Outstanding [Member]
Stock options outstanding.
Stock Options Outstanding
Operating Lease, Right-of-Use Asset
Lease right of use asset
Lease right of use assets
Minimum Beneficial Ownership Percentage
Minimum beneficial ownership percentage.
Minimum beneficial ownership percentage
Class of Warrant or Right
Class of Warrant or Right [Axis]
Technology License Agreement
Technology License Agreement [Text Block]
Technology license agreement.
Document Type
Document Type
Income Taxes Paid, Net, Total
Cash paid for taxes
Income Taxes Paid, Net
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Entity Central Index Key
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net decrease in cash, cash equivalents and restricted cash
Subsequent Event Type
Subsequent Event Type [Domain]
Change in fair value of warrant liability
Change in fair value of warrant liability
Fair Value Adjustment of Warrants
Anti-dilutive securities excluded from computation of earnings per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Common stock held by option holder in consideration of aggregate exercise price
Aggregate Exercise Price Of Common Stock Shares
Aggregate exercise price of common stock shares.
Common stock par value
Common stock, par value
Common Stock, Par or Stated Value Per Share
Share-Based Payment Arrangement, Tranche One [Member]
Tranche One
EXPIRATION DATES
Expiration dates
Class Of Warrant Or Right Expiration Dates
Class of warrant or right expiration dates.
Weighted- Average Remaining Contractual Term (In Years), Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected volatility, Maximum
Number of product candidates
Number Of Product Candidates
Number of product candidates.
Payment for license fee
Payment For License Fee
Payment for license fee.
Stock options exercised
Options exercised, Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Number of Stock Options, Shares, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance
Unvested as of June 30, 2025
Debt Disclosure [Abstract]
Accrued expenses
Accrued expenses
Accrued Liabilities, Current
Current Fiscal Year End Date
Current Fiscal Year End Date
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
Document Quarterly Report
Document Quarterly Report
Entity Address, State or Province
Entity Address, State or Province
Number of Shares Options, Unvested
Number of Shares Options, Unvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Investment, Name [Domain]
Asset Acquisition [Domain]
Total
Financial Liabilities Fair Value Disclosure
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding
Preferred stock, Shares outstanding
Preferred stock, shares outstanding
Maximum amount upon achievement of various clinical, commercial and sales milestones
Maximum Amount Upon Achievement Of Various Clinical Commercial And Sales Milestones
Maximum amount upon achievement of various clinical, commercial and sales milestones.
Common stock reserved for future issuance
Common Stock, Capital Shares Reserved for Future Issuance
Class of Warrant or Right
Class of Warrant or Right [Domain]
Geographical [Axis]
Exclusive Licensing Agreement
Exclusive Licensing Agreement [Member]
Exclusive licensing agreement.
Other General and Administrative Expense
Other general and administrative segment expenses
Number of consecutive
Number of consecutive installments.
Number of Consecutive Installments
Schedule of Stock-based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Professional Fees
Professional and consulting fees
Options exercised
Stock Issued During Period, Value, Stock Options Exercised
Interest and Other Income
Interest and other income
Interest income
Collaborative Arrangement Disclosure [Text Block]
Exclusive Licensing Agreement with a Related party
Subsequent Event
Subsequent Event [Member]
Warrants
Warrants Disclosure [Text Block]
Warrants disclosure.
Long-Term Debt, Maturity, Remainder of Fiscal Year
2025 (remaining six months)
Property, Plant and Equipment [Abstract]
Antidilutive Securities
Antidilutive Securities [Axis]
Aggregate fair value of awards that vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Intrinsic value of stock options vested
Interest Expense, Debt, Total
Interest Expense, Debt
Interest expense
Debt Instrument, Unamortized Discount, Total
Debt Instrument, Unamortized Discount
Accretion of debt discount
Less: debt discount
Related Party Transaction
Related Party Transaction [Axis]
Ending Balance, Treasury Stock, Shares
Treasury Stock, Common, Shares
Beginning Balance, Treasury Stock, Shares
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Significant accounting policies.
Issuance Costs In Accounts Payable And Accrued Expenses
Issuance costs in accounts payable and accrued expenses
Issuance costs in accounts payable and accrued expenses
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued
Preferred stock, $0.01 par value; 10,000,000 shares authorized at June 30, 2025 and December 31, 2024; no shares issued or outstanding at June 30, 2025 and December 31, 2024, respectively.
Debt Instrument, Maturity Date
Debt instrument, maturity date
Minimum
Minimum [Member]
Minimum [Member]
Weighted-Average Grant Date Fair Value, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Significant accounting policies.
Current assets:
Assets, Current [Abstract]
Level 3
Fair Value, Inputs, Level 3 [Member]
Segment Reporting [Abstract]
Schedule of Information About Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Current liabilities:
Liabilities, Current [Abstract]
Committed period to remitting in support of clinical trial
Committed Period To Remitting In Support Of Clinical Trial
Committed period to remitting in support of clinical trial.
Conditional series B warrants member.
Conditional Series B Warrants [Member]
Conditional Series B Warrants
Commitments and Contingencies
Commitments and contingencies (Note 14)
Weighted-Average Grant Date Fair Value, Unvested
Weighted-Average Grant Date Fair Value, Unvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Promissory note contractual interest rate
Promissory Note Contractual Interest Rate
Promissory note contractual interest rate.
General and Administrative
General and Administrative Expense [Member]
Operating Lease, Liability, Total
Operating Lease, Liability
Lease liability
Operating lease liability
Debt Instrument, Basis Spread on Variable Rate
Interest rate
Combination of Common Stock, Preferred Stock, Debt Securities, Warrants and/or Units
Combination of Common Stock, Preferred Stock, Debt Securities, Warrants and Units [Member]
Combination of common stock, preferred stock, debt securities, warrants and units.
Fair value of warrant liability
Warrant liability
Warrant Liability Noncurrent
Warrant liability noncurrent.
Business acquisition carrying value of note
Business Acquisition Carrying Value Of Promissory Note
Business acquisition carrying value of promissory note.
Lessee, Lease, Description [Table]
Debt instrument final payment fee percentage.
Debt Instrument Final Payment Fee Percentage
Debt instrument final payment fee percentage
Capital expenditures in accounts payable and accrued expenses
Capital Expenditures Incurred but Not yet Paid
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net income (loss)
BWH License
Brigham And Womens Hospital Inc License Agreement [Member]
Brigham and Womens Hospital, Inc License Agreement.
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average common shares outstanding, basic
Weighted-average shares of common stock outstanding - basic
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Exercisable as of June 30, 2025
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Domain]
Principal payments on term loan
Proceeds from Principal payments on term loan
Principal payments on term loan
Ventagen
Ventagen L L C [Member]
Ventagen, LLC.
Asset acquisition, assumption of promissory note.
Asset Acquisition Assumption of Promissory Note
Asset acquisition, assumption of promissory note
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Beginning Balance
Ending Balance
Equity, Attributable to Parent
Total stockholders' equity
Preferred stock par value
Preferred Stock, Par or Stated Value Per Share
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Statement of Stockholders' Equity [Abstract]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Share-Based Payment Arrangement, Tranche Two [Member]
Tranche Two
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Treasury Stock, Common [Member]
Treasury Stock Member
Over-Allotment Option [Member]
Underwriters' Overallotment Option
Leasehold Improvements
Leasehold Improvements [Member]
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value of Financial Assets and Liabilities
Fair Value Disclosures [Text Block]
Payment at the time of entering into license
Payment At Time Of Entering Into License
Payment at the time of entering into license.
Warrants and Rights Note Disclosure [Abstract]
Schedule of Accrued Expenses
Schedule of Accrued Liabilities [Table Text Block]
Debt Instrument, Name
Debt Instrument, Name [Domain]
Noncash Investing and Financing Items [Abstract]
Supplemental disclosures of non-cash information:
Stock Issued During Period, Value, Exercise Of Pre Funded Warrants
Equity impact of shares issued on exercise of pre-funded warrants.
Exercise of pre-funded warrants
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Plan Name
Plan Name [Domain]
Stock issued during period shares warrant exercised.
Stock Issued During Period Shares Warrant Exercised
Warrants exercised, Shares
Increase (Decrease) in Other Operating Assets, Total
Increase (Decrease) in Other Operating Assets
Other assets
Interest Expense, Total
Interest Expense, Operating and Nonoperating
Interest expense
Interest expense
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Related party transactions, ownership percentage
Equity Method Investment, Ownership Percentage
Class of Warrant or Right, Outstanding
Number of warrants outstanding
Treasury stock (at cost)
Treasury Stock, Value
Treasury Stock, Value, Total
Related and Nonrelated Parties [Axis]
Class Of Warrant Or Right [Table]
Class of Warrant or Right [Table]
Accounting Standards Update [Extensible Enumeration]
Entity Address, City or Town
Entity Address, City or Town
Number of reportable segment
Number of Reportable Segments
Security Exchange Name
Security Exchange Name
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]
Exercise of pre-funded warrants, Shares
Stock Issued During Period, Shares, Exercise Of Pre Funded Warrants
Stock Issued During Period, Shares, Exercise Of Pre Funded Warrants
Net carrying amount
Total principal
Long-Term Debt, Gross
Long-term debt
Property, Plant and Equipment, Gross, Ending Balance
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Total
Total fixed assets
Property, Plant and Equipment, Gross
Debt, Weighted Average Interest Rate
Weighted average effective interest rate
Issuance of common stock in registered direct offering, issuance costs
Issuance of common stock in registered direct offering, issuance costs.
Issuance of common stock in registered direct offering, issuance costs
Upfront license fee
Upfront License Fee
Upfront license fee.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
Unvested as of June 30, 2025
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Loss related to indemnification obligations
Loss Contingency, Loss in Period
Founders
Executive Officer [Member]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Interest Paid, Excluding Capitalized Interest, Operating Activity
Cash paid for interest
Statistical Measurement
Statistical Measurement [Domain]
EXERCISE PRICE PER SHARE
Exercise price per share
Class of warrants issued per share
Total current assets
Assets, Current
Share-Based Payment Arrangement, Expense
Total stock-based compensation expense
Document Period End Date
Document Period End Date
Title of Individual
Title and Position [Axis]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Exercisable as of June 30, 2025
Change in fair value of NC Ohio Trust Warrants
Adjustments to Additional Paid in Capital, Fair Value
Statement of Financial Position [Abstract]
Restricted Stock Units
Restricted Stock Units (RSUs) [Member]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Vesting [Axis]
2021 Plan
Two Thousand Twenty One Equity Incentive Plan [Member]
2021 Equity incentive plan.
Class of Stock
Class of Stock [Axis]
Estimated fair value of warrants
Warrants Not Settleable in Cash, Fair Value Disclosure
Other Receivables
Due from related parties
Total liabilities
Liabilities
Emerging Growth Company
Emerging Growth Company Policy [Text Block]
Emerging growth company.
Proceeds from issuance of common stock in registered direct offering
Proceeds from Issuance of Common Stock in Registered Direct Offering
Proceeds from issuance of common stock in registered direct offering.
Lessee, Operating Lease, Liability, to be Paid, Year Two
2027
Restricted Cash, Total
Restricted cash
Restricted Cash
Unvested Restricted Stock
Restricted Stock [Member]
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average common shares outstanding, diluted
Weighted-average shares of common stock outstanding - diluted
Weighted-average shares of common stock outstanding - diluted
Entity File Number
Securities Act File Number
Other Assets, Total
Other Assets
Other assets
Cover [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected volatility, Minimum
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Number of Shares Options, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Number of Shares Options, Forfeited
Other Long-Term Debt, Noncurrent
Other long-term debt
Number of Operating Segments
Number of operating segment
Sale of Stock
Sale of Stock [Domain]
Segment Reporting
Segment Reporting Disclosure [Text Block]
General and administrative
General and Administrative Expense
Total general and administrative
Summary of Restricted Stock Activity
Nonvested Restricted Stock Shares Activity [Table Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total
Number of Stock Options, Shares, Cancelled or forfeited or expired
Term loan.
Term Loan [Member]
Term Loan
Series B warrants.
Series B Warrants
Series B Warrants [Member]
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted and Issued Accounting Standards
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Summary of Future Lease Payments Under Non-cancelable Leases
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Loss on the sale of fixed assets
Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets, Total
Loss on the disposal of fixed assets
Estimated market rate for unsecured loan
Estimated Market Rate For Unsecured Loan
Estimated market rate for unsecured loan.
Share-based compensation arrangement by share-based payment award, award vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Liabilities:
Financial Liabilities Fair Value Disclosure [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk-free interest rate, Minimum
Depreciation expense
Depreciation
Depreciation, Total
Issuance of common stock in registered direct offering, net of issuance costs shares
Issuance of common stock in registered direct offering, net of issuance costs. shares.
Issuance of common stock in registered direct offering, net of issuance costs, Shares
Unrecognized compensation cost related to unvested stock options
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Common stock, shares, outstanding
Beginning Balance, Shares
Ending Balance, Shares
Common Stock, Shares, Outstanding
Operating Lease, Liability, Current
Current portion of lease liability
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Document Transition Report
Document Transition Report
Total operating expenses
Operating Expenses
Research and development
Research and Development Expense
Total research and development
Cost of Revenue, Total
Cost of Revenue
Related party costs
Lessee, Operating Leases [Text Block]
Lease
Statement of Cash Flows [Abstract]
Sale of stock under Shelf
Stock Issued During Period, Value, New Issues
Sale of common stock through at-the-market offerings, net of issuance costs
Schedule of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Clinical development
Business Development
Equity [Text Block]
Common Stock
Earnings Per Share [Text Block]
Net Income (Loss) Per Share
Networking and Computer Equipment
Computer Equipment [Member]
Net income (loss) and comprehensive income (loss)
Net income (loss)
Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Organization And Basis Of Presentation [Line Items]
Organization And Basis Of Presentation [Line Items]
Organization and basis of presentation.
Series B Warrant Liability
Series B Warrant Liability [Member]
Series B warrant liability.
Expense For Startup And Patient Fees For Clinical Trials
Expense for startup and patient fees for clinical trials.
Expense for startup and patient fees for clinical trials
Operating Lease, Cost
Operating lease cost
Impairment of fixed assets
Tangible Asset Impairment Charges, Total
Tangible Asset Impairment Charges
Commercial Readiness
Commercial readiness.
Commercial readiness
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Operating Lease, Payments
Operating cash flows used for operating leases
Cash paid for amounts included in measurement of lease liability
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Intrinsic value of stock options exercised
Denominator:
Earning Per Share Basic and Diluted [Abstract]
Earning per share basic and diluted.
Assets
Assets [Abstract]
Increase (Decrease) in Prepaid Expense and Other Assets, Total
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Document Fiscal Year Focus
Document Fiscal Year Focus
Public Offering [Member]
Public Offering [Member]
December 2024 Public Offering
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total
Change in fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Cash Flows from Investing Activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Interest Expense, Nonoperating
Interest Expense, Nonoperating, Total
Interest expense
Research and Development
Research and Development Expense [Member]
Issuance Costs Related To Common Stock And Accompanying Pre-funded Warrants In Public Offering
Issuance costs related to common stock and accompanying pre-funded warrants in public offering.
Issuance costs related to common stock and accompanying pre-funded warrants in public offering
Outstanding Warrants For Common Stock
Outstanding Warrants For Common Stock [Member]
Outstanding warrants for common stock.
Employee Related Research and Development
Employee related research and development.
Employee-related
Proceeds from option exercises
Proceeds from Stock Options Exercised
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One
2026
Sale of Stock, Consideration Received on Transaction
Proceeds from stock offering
Debt Instrument [Axis]
Debt Instrument
Share-Based Payment Arrangement [Abstract]
Non Rule 10b51 Arr Modified Flag
Non Rule 10b51 Arr Modified Flag.
Non-Rule 10b5-1 Arrangement Modified
Warrant Liability Current
Warrant liability current.
Warrant liability
Sale of Stock
Sale of Stock [Axis]
Net cash used in investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Title of 12(b) Security
Title of 12(b) Security
Change In Beneficial Ownership Notice Period
Change in beneficial ownership notice period.
Change in beneficial ownership notice period
Weighted-Average Grant Date Fair Value, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Related and Nonrelated Parties [Domain]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Class Of Warrant Or Right [Line Items]
Class of Warrant or Right [Line Items]
Periphagen, Inc. asset acquisition.
Periphagen Inc Asset Acquisition [Member]
Periphagen, Inc.
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2025
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Summary of Fixed Assets, Net
Property, Plant and Equipment [Table Text Block]
Weighted-Average Exercise Price, Outstanding
Weighted-Average Exercise Price, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Debt instrument accretion of debt discount.
Debt Instrument Accretion of Debt Discount
Accretion of debt discount
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Additional Paid In Capital
Additional Paid-in Capital [Member]
Past services provided by beneficiary
Past Services Provided By Beneficiary
Past services provided by beneficiary.
Measurement Frequency
Measurement Frequency [Domain]
Income Statement Location
Statement of Income Location, Balance [Axis]
ATM Program
At-the-Market Offering [Member]
At-the-market offering.
At The Market Offerings
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Trading Symbol
Trading Symbol
Fixed Assets, Net
Property, Plant and Equipment Disclosure [Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Risk-free interest rate, Maximum
Subsequent Event Type
Subsequent Event Type [Axis]
2015 Plan
Two Thousand Fifteen Stock Plan [Member]
2015 Stock Plan.
Employee-related Liabilities, Current, Total
Payroll and employee related expenses
Employee-related Liabilities, Current
Class of warrant or right exercise price per share.
Class Of Warrant Or Right Exercise Price Per Share
Class of warrant or right exercise price per share
Cash Flows from Financing Activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Expected option life (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Fair Value, Recurring
Fair Value, Recurring [Member]
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Entity Ex Transition Period
Entity Ex Transition Period
Lessee, Operating Lease, Liability, to be Paid
Total future lease payments
Total future lease payments
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: imputed interest
Less: imputed interest
Equity Components
Equity Components [Axis]
Issuance of common stock in registered direct offering, net of issuance costs
Issuance of common stock in registered direct offering, net of issuance costs.
Issuance of common stock in registered direct offering, net of issuance costs
Total other income (expense), net
Nonoperating Income (Expense)
Equity Component
Equity Component [Domain]
Business acquisition present value of future cash outflow
Business Acquisition Present Value Of Future Cash Outflow
Business acquisition present value of the future cash outflow.
Share-based compensation arrangement by share-based payment award, expiration period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Maximum
Maximum [Member]
Statistical Measurement
Statistical Measurement [Axis]
Weighted-Average Exercise Price, Exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Non-cash lease expense
Non-cash lease expense.
Non-cash lease expense
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock, $0.01 par value; 150,000,000 shares authorized at June 30, 2025 and December 31, 2024; 55,012,239 and 46,933,088 shares issued at June 30, 2025 and December 31, 2024, respectively; 54,889,631 and 46,810,480 shares outstanding at June 30, 2025 and December 31, 2024, respectively.
Principles of Consolidation
Consolidation, Policy [Policy Text Block]
Warrant liability
Warrants and Rights Outstanding
Payment from related party
Related Party Transaction, Amounts of Transaction
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Schedule of Principal Payments and Net Carrying Amount of Term Loan
Schedule of Debt [Table Text Block]
Committed amount to remitting in support of clinical trial
Committed Amount To Remitting In Support Of Clinical Trial
Committed amount to remitting in support of clinical trial.
Entity Registrant Name
Entity Registrant Name
Other Long-Term Debt
Debt Disclosure [Text Block]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Accrued interest due upon maturity period
Accrued Interest Due Upon Maturity Period
Accrued interest due upon maturity period.
Sharebased Compensation Arrangement By Sharebased Payment Award Option Unvested Weighted Average Remaining Contractual
Share based compensation arrangement by share based payment award option unvested weighted average remaining contractual.
Unvested as of June 30, 2025
Measurement Frequency
Measurement Frequency [Axis]
Net proceeds
Proceeds from Issuance of Common Stock
Proceeds from sale of common stock, net of issuance costs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Laboratory Equipment
Laboratory Equipment [Member]
Laboratory equipment.
Area of lease property
Area Of Lease Property
Area of lease property.
Payments to Acquire Property, Plant, and Equipment, Total
Purchase of fixed assets
Payments to Acquire Property, Plant, and Equipment
Rule 10b51 Arr Modified Flag
Rule 10b51 Arr Modified Flag.
Rule 10B5-1Arrangenment Modified
Number of Shares Options, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Total assets
Assets
Schedule Of Property Plant And Equipment [Table]
Property, Plant and Equipment [Table]
Restricted stock unit vesting, Shares
Stock Issued During Period Shares Restricted Stock Unit Vesting
Stock issued during period shares restricted stock unit vesting.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Exercisable as of June 30, 2025
Income Statement [Abstract]
Line of Credit Facility, Initiation Date
Loan agreement date
Stock Issued During Period, Shares, New Issues
Shares of common stock sold and issued
Sale of common stock through at-the-market offerings, net of issuance costs, Shares
Number of Shares Options, Vested
Number of Shares Options, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Payment for annual license fee
Payment For Annual License Fee
Payment for annual license fee.
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net income (loss) per share, diluted
Net income (loss) per share, diluted
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Summary of Disaggregated Amounts that Comprise Research and Development and General and Administrative Expenses
Title of Individual
Title and Position [Domain]
Asset Acquisition [Axis]
City Area Code
City Area Code
Total principal
Debt Instrument, Face Amount
Line of Credit Facility, Maximum Borrowing Capacity
Loan, maximum borrowing capacity
Variable Lease, Cost
Variable lease cost
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease term (years)
Lease Expiration Date
Lease expiration date
Lease, Cost, Total
Lease, Cost
Total lease expense
Share based compensation award tranche four member.
Share Based Compensation Award Tranche Four [Member]
Tranche Four
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Fixed assets, net
Fixed assets, net
Property, Plant and Equipment, Net
Corporate, Clinical and Manufacturing Operations
Corporate Clinical And Manufacturing Operations [Member]
Corporate clinical and manufacturing operations.
Loss from operations
Operating Income (Loss)
Loss from operations
Voting stock.
Voting Stock [Member]
Voting Stock
Accumulated Deficit
Retained Earnings [Member]
Share-based Payment Arrangement, Noncash Expense, Total
Non-cash stock compensation expense
Share-Based Payment Arrangement, Noncash Expense
Operating Lease, Liability, Noncurrent
Lease liability, net of current portion
Level 1
Fair Value, Inputs, Level 1 [Member]
Class of Stock [Line Items]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Summary of Warrants Outstanding for Purchase of Common Stock
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Share-based Compensation Arrangement by Share-based Payment Award Options Non-vested Intrinsic Value
Share-based compensation arrangement by share-based payment award options non-vested intrinsic value.
Unvested as of June 30, 2025
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Class of warrant or right issued
Class Of Warrant Or Right Issued
Class of warrant or right issued.
Third-party research and development expenses
Accrued Third Party Research And Development Expenses Current
Accrued third-party research and development expenses current.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income (Loss) Per Share
Registered Direct Offering
Registered Direct Offering [Member]
Registered direct offering.
Entity Interactive Data Current
Entity Interactive Data Current
Research and Development, Contract to Perform for Others [Table]
Increase (Decrease) in Contract with Customer, Liability
Deferred income
Income Statement Location
Statement of Income Location, Balance [Domain]
Cash Flows from Operating Activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Furniture and Fixtures
Furniture and Fixtures [Member]
Organization And Basis Of Presentation [Table]
Organization And Basis Of Presentation [Table]
Organization and basis of presentation.
Entity Tax Identification Number
Entity Tax Identification Number
Manufacturing equipment
Manufacturing Equipment [Member]
Manufacturing Equipment
Loan, maturity period
Debt Instrument, Term
Loan agreement period
Restricted stock unit vesting
Stock Issued During Period Value Restricted Stock Unit Vesting
Stock issued during period value restricted stock unit vesting.
Organization and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Weighted-average incremental borrowing rate.
Weighted-average Incremental Borrowing Rate
Weighted-average incremental borrowing rate
Unaudited Interim Financial Information
Unaudited Interim Financial Information Policy [Text Block]
Unaudited interim financial information.
Local Phone Number
Local Phone Number
Related Party Transaction
Related Party Transaction [Domain]
Accounting Policies [Abstract]
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
NC Ohio Trust
N C Ohio Trust Warrants [Member]
NC Ohio trust warrants.
General and Administrative Expense [Abstract]
General and administrative:
Class of Stock
Class of Stock [Domain]
Employee-related
Labor and Related Expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Number of shares available for grant
Stock-based awards are expected to be recognized over a weighted average period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Accrued Professional Fees, Current
Professional fees
Stock, Class of Stock [Table]
Entity Emerging Growth Company
Entity Emerging Growth Company